Skip to content

Study · Randomized controlled trial · n = 36 · 2019

2 results

Carnosine supplementation does not affect serum concentrations of advanced glycation and precursors of lipoxidation end products in autism: a randomized controlled clinical trial.

Ghodsi R, Kheirouri S, Nosrati R

Annals of clinical biochemistry6 Sept 2018Cited by 6 (Europe PMC)

PMID30089410 (opens in a new tab)DOI10.1177/0004563218796860 (opens in a new tab)PepBankPUB-30089410
Source linkPubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanRandomized controlled trialActivity measurement

    In autistic children, carnosine did not significantly alter plasma advanced glycation end products.

    In plain wordsIn autistic children, carnosine did not significantly change plasma glycation products compared with placebo.

    Peptide
    L-carnosine
    Outcome
    No significant changeAdvanced glycation end products
    Study

    n = 36

    Comparator
    Placebo
    Outcome group
    Adipokines · Metabolic and weight
    Studied dose
    500 mg daily · two monthsAs given in this study (human).

    Source sentences

    Summary
    Carnosine supplementation did not significantly alter plasma concentrations of advanced glycation end products and precursors of advanced lipoxidation end products in autistic children.
    2 context sentences
    Summary · context
    This randomized double-blind, placebo-controlled clinical trial was conducted on 36 autistic children, 18 in the carnosine group and 18 in the placebo group.
    Summary · context
    The groups received a daily supplement of 500 mg carnosine or placebo for two months, respectively.
  2. 02HumanRandomized controlled trialActivity measurement

    In autistic children, carnosine did not significantly alter plasma precursors of advanced lipoxidation end products.

    In plain wordsIn autistic children, carnosine did not significantly change plasma lipoxidation precursors compared with placebo.

    Peptide
    L-carnosine
    Outcome
    No significant changePrecursors of advanced lipoxidation end products
    Study

    n = 36

    Comparator
    Placebo
    Outcome group
    Adipokines · Metabolic and weight
    Studied dose
    500 mg daily · two monthsAs given in this study (human).

    Source sentences

    Summary
    Carnosine supplementation did not significantly alter plasma concentrations of advanced glycation end products and precursors of advanced lipoxidation end products in autistic children.
    2 context sentences
    Summary · context
    This randomized double-blind, placebo-controlled clinical trial was conducted on 36 autistic children, 18 in the carnosine group and 18 in the placebo group.
    Summary · context
    The groups received a daily supplement of 500 mg carnosine or placebo for two months, respectively.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.